Portrait of Dr. Mahmoud Desoky

Consultant Internist & Gastroenterologist

Dr. Mahmoud Desoky

Caring for patients with liver disease, teaching the next generation of physicians, and researching metabolic liver health.

About

I am a Consultant Internist and Gastroenterologist, and an Assistant Professor of Internal Medicine, with more than 25 years in medicine.

My clinical and academic work centres on metabolic dysfunction-associated steatotic liver disease (MASLD) and the wider field of metabolic liver disease. I lead a hospital tele-hepatology service, direct the Lipo-Metabolic Liver Academy, and am a certified Clinical Trial Principal Investigator.

I also teach the public: my Arabic patient-education talks help people understand and protect their liver health.

Current Roles

  1. Consultant Internist & Gastroenterologist

    Gastroenterology and hepatology

  2. Assistant Professor

    Internal medicine

  3. Certified Clinical Trial Principal Investigator

    184-hour certification programme

Programs & Initiatives

Lead

Tele-Hepatology Initiative

Hospital-based remote liver care

Bringing specialist liver care to patients through remote consultation and follow-up.

Director

Lipo-Metabolic Liver Academy

Continuing Medical Education (CME) platform

Education for clinicians on metabolic liver disease and its links with obesity, diabetes and cardiometabolic risk.

Research & Publications

Research interests:

  • MASLD
  • Metabolic liver disease
  • AI in hepatology

The complete, up-to-date list of my publications is on ORCID (0000-0002-1422-0886).

Publications

  1. El-Kassas M, AlNaamani KM, Sanai FM, Yilmaz Y, Labidi A, Mohammed MO, et al., Desoky MS. Denominator bias in MENA MASLD epidemiology: a call for decision-grade surveillance. Saudi Journal of Gastroenterology. 2026. DOI
  2. Desoky MS, El-Kassas M. Metabolic dysfunction-associated steatotic liver disease in challenging care settings: clinical implications from the MENA region. EMJ Hepatology. 2026. DOI
  3. Alzaki AA, Alqahtani MZ, Aman E, Asiri GM, Al Jibril MH, Desoky R, et al., Desoky MS. THR-β agonists vs incretin therapies for noncirrhotic MASH: a biopsy-anchored systematic review with GRADE certainty. Cureus. 2026. DOI
  4. Al-Juhani AA, Alzaki AA, Maghrabi EF, Rambo R, AlGhamdi A, Alanazi NA, Desoky R, Desoky MS. Artificial intelligence-assisted capsule endoscopy for obscure small-bowel bleeding: a systematic review of workflow gains and the unmeasured impact on patient-centred outcomes. Cureus. 2025. DOI
  5. Al-Juhani AA, Desoky R, Almutiri N, et al., Desoky MS. Nanotechnology-enhanced materials and smart implants in general surgery: a systematic review of human clinical outcomes. Cureus. 2025. DOI
  6. Al-Juhani AA, Desoky MS, Ahmad MN, et al., Desoky R. Tenapanor for irritable bowel syndrome with constipation (IBS-C): a systematic review of randomized trials assessing FDA composite response, durability, and risk of bias. Cureus. 2025. DOI
  7. Alshammari N, Aladel A, Desoky MS, AlThuneyyan D, Altimyat HF, Alsoqeah FF, Hashem M, Abulmeaty MMA. Validation of GLIM criteria for diagnosis of malnutrition in stroke survivors. Frontiers in Nutrition. 2025. DOI
  8. Al-Juhani AA, Desoky MS, Almuhaimid AA, Zaheer M, Alhaqbani HF, Abalkhail EA, Alanazi SA, Alzahrani RS, Alrefaai M, Desoky R. Efficacy of gut microbiome-targeted therapies in modulating systemic inflammation and low-grade chronic inflammatory states in adults with metabolic disorders: a systematic review. Cureus. 2025. DOI
  9. Altimyat HF, Aladel A, Desoky MS, AlThuneyyan D, Alshammari N, Alagel L, Aljabri L, Desoky RM, Abulmeaty MMA. Effect of feeding route and stroke type on gastric myoelectric activity in stroke survivor patients: a preliminary study. Journal of Clinical Medicine. 2025;14(17):5976. DOI
  10. Abulmeaty MMA, Altimyat HF, Aladel A, Desoky M, AlThuneyyan D, Alshammari N, Aboughanima N, Alagel L, Aljabri L. Gastric myoelectric activity changes in post-stroke survivors with dysphagia under different feeding routes. Clinical Nutrition ESPEN. 2024;63:245–252. DOI
  11. Alshammari NN, Aladel A, Desoky MS, AlThuneyyan DA, Altimyat HF, Alsoqeah FF, Hashem M, Abulmeaty MMA. Are the GLIM criteria valid for the diagnosis of malnutrition in stroke survivors? Clinical Nutrition ESPEN. 2024;63:728–733. DOI
  12. AlThuneyyan D, Aladel A, Desoky MS, Alshammari N, Alsoqeah FF, Altimyat HF, Abulmeaty MMA. Effects of feeding with varying consistency on gastric myoelectric activity in adult patients with swallowing difficulties. Clinical Nutrition ESPEN. 2024;63:760–765. DOI
  13. Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, et al., Desoky MS. Global multi-stakeholder endorsement of the MAFLD definition. The Lancet Gastroenterology & Hepatology. 2022. DOI
  14. Desoky MS, Al-Dahrouty AH, Abdlrehem E, Mokareb H. Role of right liver lobe diameter/albumin ratio in the assessment of esophageal varices in Egyptian patients with liver cirrhosis. Minia Journal of Medical Research. 2014;25(2):45–52.

Lectures & Talks

Professional talks

    Patient education توعية المرضى

    Talks for patients and families, in Arabic. Each opens on YouTube.

    Events

    Upcoming

    Past

    Teaching & Education

    • Assistant Professor: undergraduate and postgraduate teaching in internal medicine, and supervision of postgraduate theses.
    • Lipo-Metabolic Liver Academy: Director of a continuing medical education platform on metabolic liver disease for practising clinicians.
    • Invited faculty: annual interdisciplinary Neurogenic Bladder & Bowel course (2024 to 2026).

    Memberships

    • SLMENA
    • EASL
    • MENASL